Serotonin-selective reuptake inhibitors and nonsteroidal anti-inflammatory drugs--important considerations of adverse interactions especially for the treatment of myalgic encephalomyelitis/chronic fatigue syndrome

J Clin Psychopharmacol. 2011 Aug;31(4):403-5. doi: 10.1097/JCP.0b013e318225848c.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Animals
  • Anti-Inflammatory Agents, Non-Steroidal / adverse effects
  • Anti-Inflammatory Agents, Non-Steroidal / metabolism
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
  • Antidepressive Agents / adverse effects
  • Antidepressive Agents / metabolism
  • Antidepressive Agents / therapeutic use
  • Drug Interactions / physiology
  • Fatigue Syndrome, Chronic / drug therapy*
  • Fatigue Syndrome, Chronic / metabolism
  • Gastrointestinal Hemorrhage / chemically induced
  • Gastrointestinal Hemorrhage / metabolism
  • Humans
  • Serotonin Uptake Inhibitors / adverse effects
  • Serotonin Uptake Inhibitors / metabolism
  • Serotonin Uptake Inhibitors / therapeutic use*
  • Treatment Outcome

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Antidepressive Agents
  • Serotonin Uptake Inhibitors